AYTUHealthcareNano-Cap

AYTU BIOPHARMA, INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for AYTU BIOPHARMA, INC (AYTU), sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Are AYTU insiders buying or selling?

AYTU BIOPHARMA, INC insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 19 Form 4 filings for AYTU: 15 buys ($8.7M) and 4 sells ($40.6M).

Source: SEC EDGAR Form 4

Key Statistics (March 2018 – Jun 10, 2025)

Total Form 4 filings
19
SEC EDGAR
Insider filers
7
Insider buys (15)
$8.7M
Insider sells (4)
$40.6M

Insider sentiment

Net selling

Net insider flow of $32.0M in net selling since March 2018.

Recent AYTU insider transactions

DateInsiderRoleTypeSharesPriceValueFiling
Jun 10, 2025Jarrett DisbrowChief Business OfficerPurchase16.7K$1.50$25.0KSEC ↗
Jun 10, 2025Joshua R. DisbrowChief Executive OfficerPurchase66.7K$1.50$100.0KSEC ↗
Mar 3, 2025Joshua R. DisbrowChief Executive OfficerPurchase15.0K$1.30$19.5KSEC ↗
Jun 20, 2023Greg PyszczymukaChief Commerical OfficerPurchase12.0K$1.87$22.4KSEC ↗
Jun 15, 2023Joshua R. DisbrowChief Executive OfficerPurchase14.0K$1.86$26.1KSEC ↗
Dec 21, 2022Joshua R. DisbrowChief Executive OfficerPurchase112.4K$0.22$25.0KSEC ↗
Dec 21, 2022Greg PyszczymukaChief Commercial OfficerPurchase100.0K$0.24$24.5KSEC ↗
Nov 28, 2022Mark K OkiChief Financial OfficerPurchase90.0K$0.23$20.7KSEC ↗
Nov 28, 2022Joshua R. DisbrowChief Executive OfficerPurchase222.0K$0.24$52.6KSEC ↗
Dec 16, 2020Steven BoydDirectorPurchase1.3M$6.00$8.0MSEC ↗
Apr 30, 2020Steven BoydDirectorSale5.1M$1.82$9.3MSEC ↗
Apr 27, 2020Cerecor Inc.10% OwnerSale92.8K$1.55$144.1KSEC ↗
Mar 12, 2020Steven BoydDirectorSale22.0M$1.42$31.2MSEC ↗
Dec 23, 2019Steven BoydDirector, 10% OwnerPurchase78.8K$0.86$67.7KSEC ↗
Dec 19, 2019Joshua R. DisbrowChief Executive OfficerPurchase55.0K$0.89$48.8KSEC ↗
Dec 26, 2018David A GreenChief Financial OfficerSale3.3K$0.81$2.7KSEC ↗
Mar 7, 2018Joshua R. DisbrowChief Executive OfficerPurchase226.1K$0.45$101.7KSEC ↗
Mar 7, 2018David A GreenChief Financial OfficerPurchase66.6K$0.45$30.0KSEC ↗
Mar 7, 2018Jarrett DisbrowChief Operating OfficerPurchase226.1K$0.45$101.7KSEC ↗

Showing the 19 most recent of 19 Form 4 filings for AYTU BIOPHARMA, INC.

Most active AYTU insiders

  • Joshua R. Disbrow7 filings
  • Steven Boyd4 filings
  • David A Green2 filings
  • Greg Pyszczymuka2 filings
  • Jarrett Disbrow2 filings

Ask anything about AYTU insider activity

Use Trabud's AI agent to query AYTU BIOPHARMA, INC's Form 4 history in plain English — "Show me AYTU CEO purchases this year" or compare it against any other ticker.

Open the AI agent

AYTU insider trading FAQ

Are AYTU BIOPHARMA, INC insiders buying or selling?

AYTU BIOPHARMA, INC insiders reported no open-market purchases or sales in the last 12 months. Since March 2018, Trabud has recorded 19 Form 4 filings for AYTU: 15 buys ($8.7M) and 4 sells ($40.6M). Over the full record that is net selling of $32.0M.

How many insiders trade AYTU stock?

7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AYTU BIOPHARMA, INC. The most recent filing was accepted on Jun 10, 2025.

Where does Trabud get AYTU insider trading data?

All AYTU insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Related Content